rivaroxaban viatris (previously rivaroxaban mylan)
mylan ireland limited - rivaroxaban - venous thromboembolism; pulmonary embolism; acute coronary syndrome; stroke; coronary artery disease; peripheral arterial disease; atrial fibrillation - Αντιθρομβωτικοί παράγοντες - rivaroxaban mylan co-administered with acetylsalicylic acid (asa) alone or with asa plus clopidogrel or ticlopidine, is indicated for the prevention of atherothrombotic events in adult patients after an acute coronary syndrome (acs) with elevated cardiac biomarkers. rivaroxaban mylan co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (cad) or symptomatic peripheral artery disease (pad) at high risk of ischaemic events. ------prevention of venous thromboembolism (vte) in adult patients undergoing elective hip or knee replacement surgery. treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults. -------adults prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing from 30 kg to 50 kg after at least 5 days of initial parenteral anticoagulation treatment. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing more than 50 kg after at least 5 days of initial parenteral anticoagulation treatment.
naxat 15mg film coated tablets
delorbis pharmaceuticals ltd (0000009620) 17 athinon street, ergates industrial area, lefkosia, 2081, 28629 - rivaroxaban - film coated tablets - 15mg - rivaroxaban (8000003442) 15mg
naxat 20mg film coated tablets
delorbis pharmaceuticals ltd (0000009620) 17 athinon street, ergates industrial area, lefkosia, 2081, 28629 - rivaroxaban - film coated tablets - 20mg - rivaroxaban (8000003442) 20mg
enkia 20mg film coated tablets
medochemie ltd (0000003169) 1-10 constantinoupoleos str, lemesos, 3011, 51409 (3505) - rivaroxaban - film coated tablets - 20mg - rivaroxaban (8000003442) 20mg
enkia 15mg film coated tablets
medochemie ltd (0000003169) 1-10 constantinoupoleos str, lemesos, 3011, 51409 (3505) - rivaroxaban - film coated tablets - 15mg - rivaroxaban (8000003442) 15mg
nepanizil f.c.tab 5mg/tab
medicair bioscience laboratories cy ltd, cyprus Ανεξαρτησίας 3, 3036 Λεμεσός - donepezil hydrochloride - f.c.tab (ΕΠΙΚΑΛΥΜΜΕΝΟ ΜΕ ΛΕΠΤΟ ΥΜΕΝΙΟ ΔΙΣΚΙΟ) - 5mg/tab - donepezil hydrochloride 5mg - donepezil
nepanizil f.c.tab 10mg/tab
medicair bioscience laboratories cy ltd, cyprus Ανεξαρτησίας 3, 3036 Λεμεσός - donepezil hydrochloride - f.c.tab (ΕΠΙΚΑΛΥΜΜΕΝΟ ΜΕ ΛΕΠΤΟ ΥΜΕΝΙΟ ΔΙΣΚΙΟ) - 10mg/tab - donepezil hydrochloride 10mg - donepezil
montelukast/medical chw.tab 4mg/tab
ΠΝΓ ΓΕΡΟΛΥΜΑΤΟΣ ΜΕΝΤΙΚΑΛ Α.Ε. Δ.Τ.png gerolymatos medical ae Ασκληπιού 13,, 145 68 145 68, Κρυονέρι Αττικής 210.8194200 - montelukast sodium - chw.tab (ΜΑΣΩΜΕΝΟ ΔΙΣΚΙΟ) - 4mg/tab - montelukast sodium 4,15mg - montelukast
tanaren 4mg/tab μασωμενο δισκιο
santa pharma a.e. - ΤΟ montelukast sodium - ΜΑΣΩΜΕΝΟ ΔΙΣΚΙΟ - 4mg/tab - ineof01106 - montelukast sodium - 4.150000 mg - montelukast
lixiana
daiichi sankyo europe gmbh - edoxaban tosilate - stroke; venous thromboembolism - Αντιθρομβωτικοί παράγοντες - Πρόληψη του εγκεφαλικού επεισοδίου και συστηματική εμβολή σε ενήλικες ασθενείς με nonvalvular κολπική μαρμαρυγή (nvaf) με έναν ή περισσότερους παράγοντες κινδύνου, όπως συμφορητική καρδιακή ανεπάρκεια, υπέρταση, ηλικίας ≥ 75 ετών, σακχαρώδης διαβήτης, προηγούμενη εγκεφαλικό επεισόδιο ή παροδική ισχαιμική προσβολή ( tia). Θεραπεία της φλεβικής θρόμβωσης (ΕΒΦΘ) και της πνευμονικής εμβολής (πε), και πρόληψη υποτροπιάζουσας ΕΒΦΘ και πε σε ενήλικες.